No Data
Vaccine Stocks Drop on Worries About an RFK Jr. Role -- WSJ
BioNTech Is Maintained at Hold by TD Cowen
A Quick Look at Today's Ratings for BioNTech(BNTX.US), With a Forecast Between $110 to $145
Promising Developments in BioNTech's Oncology Pipeline Drive Buy Rating
BioNTech Analyst Ratings
Tempus Stock Declines Despite Q3 Earnings & Revenues Beat Estimates